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Abstract
The ApoE ε4 allele is the most significant genetic risk factor for late-onset Alzheimer dis-
ease. The risk conferred by ε4, however, differs across populations, with populations of Afri-
can ancestry showing lower ε4 risk compared to those of European or Asian ancestry. The
cause of this heterogeneity in risk effect is currently unknown; it may be due to environmen-
tal or cultural factors correlated with ancestry, or it may be due to genetic variation local to
the ApoE region that differs among populations. Exploring these hypotheses may lead to
novel, population-specific therapeutics and risk predictions. To test these hypotheses, we
analyzed ApoE genotypes and genome-wide array data in individuals from African Ameri-
can and Puerto Rican populations. A total of 1,766 African American and 220 Puerto Rican
individuals with late-onset Alzheimer disease, and 3,730 African American and 169 Puerto
Rican cognitively healthy individuals (> 65 years) participated in the study. We first assessed
average ancestry across the genome (“global” ancestry) and then tested it for interaction
with ApoE genotypes. Next, we assessed the ancestral background of ApoE alleles (“local”
ancestry) and tested if ancestry local to ApoE influenced Alzheimer disease risk while con-
trolling for global ancestry. Measures of global ancestry showed no interaction with ApoE
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risk (Puerto Rican: p-value = 0.49; African American: p-value = 0.65). Conversely, ancestry
local to the ApoE region showed an interaction with the ApoE ε4 allele in both populations
(Puerto Rican: p-value = 0.019; African American: p-value = 0.005). ApoE ε4 alleles on an
African background conferred a lower risk than those with a European ancestral back-
ground, regardless of population (Puerto Rican: OR = 1.26 on African background, OR =
4.49 on European; African American: OR = 2.34 on African background, OR = 3.05 on Euro-
pean background). Factors contributing to the lower risk effect in the ApoE gene ε4 allele
are likely due to ancestry-specific genetic factors near ApoE rather than non-genetic ethnic,
cultural, and environmental factors.
Author summary
The strongest risk gene identified for late-onset Alzheimer disease is ApoE. However, the
risk for Alzheimer disease due to ApoE is not consistent across populations. For example,
individuals with African ancestry experience less risk from ApoE ε4 than individuals
of European or Asian ancestry. The cause of the difference in risk effect is currently
unknown. This has led us to ask: What is/are the factor(s) contributing to the risk effect
variation of ApoE across the populations? We hypothesized two possibilities for the vari-
ability of ApoE risk: 1) ethnic-related environmental factors that vary across populations,
such as diet and lifestyle activities, or 2) a population-specific genetic difference in the
ApoE gene, or in its surrounding region. We tested our hypothesis using populations with
more than one genetic ancestral background, specifically African Americans and Puerto
Ricans. Our study showed that the risk of Alzheimer disease is lower for individuals who
inherited the genomic region surrounding the ApoE gene from an African ancestor than
it is for risk allele carriers who inherited the region from a European ancestor. These find-
ings suggest that protective genetic variant(s) most likely lie(s) within the genetic region
surrounding the ApoE gene on the African ancestral background.
Introduction
Late-onset Alzheimer disease (LOAD) is a progressive neurodegenerative disorder character-
ized by loss of memory and other cognitive functions. It is the most common form of dementia
worldwide [1], with prevalence increasing with age (e.g., ~30–40% by 85–89 years) [2]. The eti-
ology of AD is multifactorial with genetic, and environmental factors all influencing risk.
The most significant genetic risk factor for LOAD is the ApoE gene [3,4]. Three common
ApoE alleles have been identified (ε2, ε3, and ε4). The ε3 allele is the most frequent and is typi-
cally considered “neutral” regarding AD risk. The ApoE ε4 allele both increases the risk and
decreases the age-of-onset of developing AD [4]. Conversely, the ε2 allele is protective against
AD [4,5]. Although ApoE is an AD risk factor in nearly all populations, the risk of AD for ε4
carriers differs among racial/ethnic groups [6]. The strongest reported risk for ε4 allele is in
East-Asian populations (ε3/ε4 odds ratio OR: 3.1–5.6; ε4/ε4 OR: 11.8–33.1) [6,7] followed by
non-Hispanic Whites (NHW) (ε3/ε4 odds ratio [OR]: 3.2; ε4/ε4 OR: 14.9) [6,8–10] with a
considerably lower risk to develop AD for an ε4 carrier in African-Ancestry populations, such
as African Americans (AA) and Caribbean Hispanics (CHI). Studies in African-ancestry
cohorts consistently reported significant association between ApoE ε4 homozygosity and AD,
but showed inconsistent results for ε4 heterozygote allele individuals (ε3/ε4 OR:1.1–2.2; ε4/ε4
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OR: 2.2–5.7) [6,8–13]. The reason for this heterogeneous risk effect of ApoE is currently
unknown. This disparity in risk may be due to ethnic-related environmental factors that vary
across populations, such as diet and lifestyle activities, or the difference may be due to popula-
tion-specific genetic factors. Exceptions include studies among the Wadi Ara and American
Indian populations, but these studies may suffer from low power due to small sample sizes
[14–16].
Ancestral methods examining both global (GA) and local (LA) ancestry can be used to
explore these different hypotheses. GA refers to an individual’s average ancestry across his/
her entire genome while LA refers to the ancestral background of a particular (i.e., “local”)
chromosomal region within an individual genome (Fig 1). GA is predominantly correlated
with ethnic, cultural, and environmental factors that are related to broader definitions of
race and ethnicity [17–20]. Conversely, LA is often correlated with ancestry-specific genetic
factors that are located in or near the genomic region in question [21,22]. As such, an under-
standing of LA around the ApoE region may help inform how we interpret the race/ethnicity
differences observed in ε4 risk. Specifically, if cultural and environmental effects play a
major role in ApoE heterogeneity, we would expect GA to interact with ε4 to influence AD
risk. There will also be GA and allele interaction if there is epistasis with alleles on other
choromsomes that have different frequencies between ancestral populations. However, if
genetic modifiers or protective factors local to the ApoE region (e.g., cis-acting enhancers,
eQTL, etc.) play a major role in ApoE ε4 heterogeneity, we would expect LA to interact with
ε4 to influence AD risk.
Admixed populations, due to their ancestral heterogeneity, often show complex patterns of
GA and LA, enabling us to test these hypotheses. As such, we utilized two admixed populations
(CHI from Puerto Rico (PR), and AA) to assess the relationship between ApoE ε4 risk and pat-
terns of GA and LA. PR individuals commonly have European (EU), African (AF) and Amer-
indian (AI) ancestors, while AA individuals often have both EU and AF ancestors. To test the
hypothesis that the population-specific risk is due to ethnic-related environmental factors that
vary across populations, we compared those ApoE ε4 carriers who inherited most of their
chromosomes from AF ancestors to those who inherited most of their chromosomes from
their EU ancestors by using GA. If there are additional genomic loci outside of the ApoE gene
contributing to the population risk difference, then individuals with the highest GA load of
EU (or AF) ancestry would match the EU (or AF) population risk. Alternatively, to test the
hypothesis that the disparity in risk may be due to genetic modifiers or protective factors local
to ApoE, we compared the LAs in the admixed populations with those of the corresponding
ancestral population (e.g., if one inherited his/her ApoE LA from the EU ancestors, his/her risk
for AD would be similar to the EU population risk).
Our results strongly suggest that an ancestry-specific region surrounding the ApoE gene is
contributing to the lower risk of AD in AA and PR ε4 carriers, supporting the hypothesis that
the “protective” effect is due to the ancestry-specific genetic factors around the ApoE genomic
region.
Results
First, we performed two genotype-based regression tests to assess global ancestry and local
ancestry interaction with ApoE genotype (see Methods for details). Results showed that the
LA by ApoE interaction term (dose of AF ancestry by dose of ε4 allele; LAxApoE) was signifi-
cantly different from 0 in both PR and AA populations (PR: likelihood ratio test (LRT), p-
value = 0.019; AA: LRT, p-value = 0.005). The effect size of the interaction term was negatively
correlated with AD (PR: OR = 0.2 (CI: 0.05–0.76); AA: OR = 0.75 (CI: 0.61–0.91)). This was in
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contrast to the GA by ApoE interaction term (GAxApoE), which was not significant in either
PR or AA (PR: LRT, p = 0.49; AA: LRT, p-value = 0.65).
Since we identified a significant interaction, we performed a haplotype-based regression
test to assess the effect size of ancestry-specific alleles (see Methods for details). We found that
the effect size of the ε4 risk allele was significant across the ancestral haplotypes, even while
accounting for correlations with GA (Table 1). In the PR dataset, the ε4 alleles on an EU
ancestral background were significantly associated with AD (p-value = 3.7e-05; OR = 4.49)
Fig 1. Illustration of local and global ancestry. This figure represents chromosome 19 from Puerto Rican, African
American, and European ancestry individuals. (A) The colored chromosomal segments represent the admixture blocks
“local” to each genomic region, with each ancestry coded by a different color (red: African (AF), blue: European (EU),
green: American Indian (AI)). (B) The global ancestry estimated by the average ancestry across the whole genome. The
Puerto Rican individual has one African block and one European block around ApoE (represented by the dashed line);
that is, the local ancestry around ApoE is African/European for this individual. The African American individual,
though mostly African genome-wide, also has African/European local ancestry at the ApoE gene.
https://doi.org/10.1371/journal.pgen.1007791.g001
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compared to ε3 alleles from an EU ancestral background. However, ε4 vs ε3 showed no signif-
icant effect on the AF LA background (p-value = 0.67; OR = 1.26). Similarly, in the AA dataset,
the ε4 haplotypes of EU ancestry showed a stronger risk effect (OR = 3.05; p-value = 4.9e-17)
than those in the AA dataset of AF ancestry (OR = 2.34; p-value = 9.2e-45). We tested the dif-
ference between the effect sizes of ancestral backgrounds by using t-test for means. Test results
showed that effect sizes between the ancestral backgrounds are different with nominal signifi-
cance in both populations (PR: p-value = 0.059; AA: p-value = 0.068). It is of note that these
models all include GA as covariates, indicating that the effects seen are independent of the GA.
In the subgroup of individuals with homozygote ε4 and ε3 alleles, results showed that
ε4 haplotypes of EU ancestry have a stronger risk effect (OR = 18.44 (CI: 9.6–35.6); p-
value = 3.5e-18) than those with AF ancestry (OR = 6.48 (CI: 3.4–12.5); p-value = 4.3e-63).
The t-test of means showed that effect sizes of EU and AF backgrounds are significantly differ-
ent (p-value = 0.003).
Since we observed that AF ancestral background surrounding the ApoE gene is contribut-
ing to the lower risk of AD, we examined the genetic region surrounding ApoE by using 1000
Genome sequence data from three populations of the Utah Residents with Northern and
Western European Ancestry (CEU), Japanese in Tokyo (JPT), and Yoruba in Ibadan (YRI).
We identified 43 variants using Pearson’s chi-square test between the CEU vs. YRI and JPT vs.
YRI populations, which were significant following the Bonferroni correction for multiple com-
parisons. Table 2 shows the list of 15 most significant variants with the Bonferroni corrected
Table 1. Haplotype analysis results, ApoE ε3 vs ApoE ε4, by cohort and haplotype local ancestry.
Cohort Haplotype Ancestry N� ε4 OR %95 CI p-value t-test for means
Puerto Rican European 307 4.49 2.2–9.2 3.7e-05 0.059
African 67 1.26 0.4–3.7 6.7e-01
African American European 1341 3.05 2.4–3.9 4.9e-17 0.068
African 5587 2.34 1.8–3.0 9.2e-45
� number of haplotypes used in model
https://doi.org/10.1371/journal.pgen.1007791.t001
Table 2. Top list of the potential protective variants at the local ancestry blocks surrounding the ApoE gene.
Marker ID Base Position Reference Allele Alternative Allele Bonferroni corrected p-values
CEU vs. YRI JPT vs.YRI
rs6857 45392254 C T 8.44E-12 5.88E-06
rs157590 45398716 A C 1.31E-09 5.85E-07
rs157588 45398264 C T 1.31E-09 5.85E-07
rs157585 45397512 A C 1.31E-09 5.85E-07
rs769449 45410002 G A 1.31E-09 5.85E-07
rs157584 45396899 T C 6.45E-09 5.85E-07
rs111789331 45427125 T A 6.45E-09 4.75E-09
rs12721046 45421254 G A 6.45E-09 3.71E-10
rs142042446 45386467 G GTAA 3.02E-08 5.85E-07
rs71352238 45394336 T C 3.02E-08 5.85E-07
rs12972156 45387459 C G 3.02E-08 5.85E-07
rs12972970 45387596 G A 3.02E-08 5.85E-07
rs34342646 45388130 G A 3.02E-08 5.85E-07
rs66626994 45428234 G A 4.37E-08 4.97E-08
https://doi.org/10.1371/journal.pgen.1007791.t002
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p-values less than 1 ×10−5. The whole list of variants is shown in the S2 Table. Fig 2 demon-
strates Bonferroni corrected p-values for the pairwise comparisons between CEU and YRI,
and JPT and YRI populations. The primary CEU and JPT peaks align, and lie within the stron-
gest Topologically Associated Domain (TAD) containing the ApoE gene. None of the signifi-
cantly different variants were in the protein-coding DNA in the defined region around the
ApoE gene. It is noteworthy that just 6 variants in sequence data comparison showed signifi-
cant difference (with the lowest p-value = 0.0052) between the CEU and JPT and all of them
were found out of the TAD region containing the ApoE.
Discussion
These findings strongly support our hypothesis that genetic modifiers local to the ApoE region
influence the risk of the ε4 allele, showing a weaker risk effect on the AF ancestral background
Fig 2. Bonferroni corrected p-values for the pairwise comparisons of the allele frequencies in 1000 Genome sequence data between (A) CEU and
YRI, and (B) JPT and YRI populations. Red region represents topologically associated domain, containing ApoE.
https://doi.org/10.1371/journal.pgen.1007791.g002
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and stronger effect on the EU ancestral background. There was no evidence that overall ances-
try (GA) has an effect on the heterogeneity of ApoE ε4 risk within the populations, which we
used as a surrogate for non-genetic cultural/ethnic differences. Additionally, we observed a
stronger risk effect on the EU ε4 haplotypes (or conversely, a protective effect on AF ε4 haplo-
types). This effect was especially pronounced in an analysis of ε4 homozygotes against ε3
homozygotes, a result consistent with previous reports on ApoE risk across populations
[6,8–13].
The overlapping of the subTAD (~50kb) region and the peaks of the allele frequency differ-
ences between the CEU, JPT and YRI support the hypothesis that the variant(s) modifying ε4
risk are most likely to lie in this region. The significant differences found in non-protein-cod-
ing DNA, suggests the protective effect is due to a regulatory difference between the local
ancestries. This would also suggest that possible a modifier(s) would affect ApoE expression
itself and supports the hypothesis that the genomic region surrounding ApoE with AF back-
ground reduces the risk for ε4 carriers and is evidence that genetic factors may be underlying
the discrepancy in ε4 allele risk effect across populations.
It should be noted that this study was not well-powered to test AI background influence on
ε4 risk allele. Further research is needed to study populations with higher AI ancestral back-
ground, such as Peruvian, Mexican, and Central American populations, to understand the cor-
relation between the AI ancestry and ApoE. Similarly, limitations in sample size prevented us
from assessing effects in ε2 carriers.
Our findings suggest that the ApoE region from AF populations may contain protective fac-
tors that help mitigate the effect of the ε4 allele. In particular, comprehensive analysis of the
ApoE region and testing for protective loci may reveal previously unappreciated biological
pathways and provide translational opportunities. Research that focuses on locating protective
variants represents a complementary approach to accelerating the identification of more effec-




All AA cases and controls selected for genotyping were obtained from the John P. Hussman
Institute for Human Genomics (HIHG) at the University of Miami Miller School of Medicine
(Miami, FL), North Carolina A&T State University (Greensboro, NC), Case Western Reserve
University (Cleveland, OH), and the Alzheimer’s Disease Genetic Consortium (ADGC). Sam-
ples were collected as described previously [23,24]. The AA dataset contained 1,766 AD cases
(69.8% female, mean age at onset (AAO) 77.6 years [SD 8.2]) and 3,730 cognitively healthy
controls (72.0% female, mean age-of-examination (AOE) 76.5 years [SD (8.3)]).
PR individuals were ascertained as a part of the Puerto Rico Alzheimer Disease and Related
Disorders Initiative study. Ascertainment was focused in metropolitan areas of New York,
North Carolina, Miami, and Puerto Rico. Participants were recruited and enrolled after they
(or a proxy) provided written informed consent and with approval by the relevant institutional
review boards. For the PR cohort, 220 unrelated cases (69.6% female, mean AAO 75.1 years
[SD 9.7]) and 169 unrelated cognitively intact controls (66.4% female, mean AOE 73.6 years
[SD 7.1]) were ascertained.
For both AA and PR datasets, cases were defined as individuals with AD with AAO>65
years of age; controls were defined as individuals with no evidence of cognitive problems and
AOE>65 years of age. All participants were evaluated to determine case or control status
based on the National Institute of Neurological and Communicative Disorders and Stroke—
ApoE e4 risk in Alzheimer disease and genetic ancestry
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Alzheimer’s Disease and Related Disorders Association, criteria [25,26]. Individuals with
known or suspected dementia were evaluated using the LOAD study reference [27]. Individu-
als who were deemed to be cognitively normal were screened with the Mini-Mental State
Examination [28] or the Modified Mini-Mental State [29]. The participants were classified as
AA and PR based on self-report, and the GWAS analysis confirmed these data.
Genotyping and quality control procedures
Genome-wide single-nucleotide polymorphism (SNP) genotyping was processed on three dif-
ferent platforms: Expanded Multi-Ethnic Genotyping Array, Illumina 1Mduo (v3) and the
Global Screening Array (Illumina, San Diego, CA, USA). ApoE genotyping was performed as
in Saunders et al. [30]. Quality control analyses were performed using the PLINK software, v.2.
[31]. The samples with a call rate less than 90% and with excess or insufficient heterozygosity
(+/- 3 standard deviations) were excluded. Sex concordance was checked using X chromosome
data. To eliminate duplicate and related samples, relatedness among the samples was estimated
by using identity by descent (IBD). SNPs with minor allele frequencies less than 0.01 and SNPs
available in samples with the call rate less than 97%, or those not in Hardy-Weinberg equilib-
rium (p<1.e-5), were eliminated from further analysis [32]. Further details of the QC analysis
can be found in the Supplement (S1 Table).
To explore the reasons for the differences in ε4 allele risk between the populations we first
assessed the genetic ancestry (LA and GA), and then tested the effect of LA and GA on the ε4
allele by building three logistic regression models.
Assessment of genetic ancestry
To assess the LA, we phased our datasets independently applying the SHAPEIT tool ver. 2 [33]
using 1000 Genomes Phase 3 reference panel [34] with default settings. We defined a region
around the ApoE that was broad enough (chr19: 44,000,000–46,000,000) to include potential
enhancers, topological associated domains, etc. while narrow enough to ensure contiguous LA
blocks for most individuals in the study. After selecting the ApoE region, we used RFMix [35],
discriminative modeling approach, to infer LA at loci across the genome. We ran RFMix with
the TrioPhased option and a minimum node size of 5. We used Human Genome Diversity
Project (HGDP) data as the reference panel; two for AA (EU, and AF), and three for PR
(EU, AF, and AI). Then, we eliminated samples with ancestral break points across the 2Mb
window (N = 892) and labeled each admixture block using the RFMix estimates. As a result,
we obtained haplotype data with three LA states (AF, EU, AI) in PRs and two (AF, EU) in
AAs. Afterwards, we defined haplotypes according to LA states and ApoE variants. S1 Fig illus-
trates the defining of LA at the ApoE gene and S2 Table shows the number of e3 and e4 alleles
along AF and EU local ancestry in each population for cases and controls.
Next, we assessed GA by performing principal components analysis (PCA) using the Eigen-
strat program [36]. The AA and PR datasets were combined with reference panels (using
HGDP reference panels) representing diverse ancestries: EU and AF for AA, and EU, AF and
AI for PR.
Statistical analyses
To assess the effects of GA and LA on ε4 risk we used three logistic regression-based models.
The first model utilized a genotype-based test to assess GA interaction with ApoE genotype.
This model evaluated the role of GA and factors strongly correlated with GA (e.g., ethnic-
related environmental factors) on ApoE risk variation among populations. The second model
utilized a genotype-based approach to assess LA interaction with ApoE genotype. In this
ApoE e4 risk in Alzheimer disease and genetic ancestry
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model, we examined the role of genetic modifiers or protective factors local to ApoE in risk
variation. The third model utilized a haplotype-based approach to assess the effect sizes of
ancestry-specific alleles (e.g., ε4 and ε3 alleles on the AF background) while accounting for
correlations with GA. Statistical analyses were performed using the “GLM2” [37] and “GEE”
[38] packages available in R computing environment.
Global ancestry by ApoE interaction. We tested the significance of the GA by ApoE
genotype interaction (GAxApoE) using the LRT. To assess the influence of the GAxApoE on
AD we used an age- and sex-adjusted logistic regression model. A “full model” was built that
included homozygote (ε4/ε4) and heterozygote (ε3/ε4) genotypes (with ε3/ε3 being the refer-
ent) as well as measures of GA (PC1, PC2, and PC3), and GAxApoE (Eq 1). This full model
was tested (by the LRT) against a reduced model without the interaction terms.
AD � Ageþ Sexþ GAþ ApoEþ GA x ApoE ð1Þ
Local ancestry by ApoE interaction. LA interaction was tested in a similar fashion; indi-
viduals were assigned LA “types” (for AA individuals: AF/AF, AF/EU, EU/EU; for PR individ-
uals AF/AF, AF/EU, AF/AI, EU/EU, EU/AI, AI/AI). LA by ApoE interaction was tested by
comparing a full model to a reduced model. The full model (Eq 2) included homozygote (ε4/
ε4) and heterozygote (ε3/ε4) genotypes (with ε3/ε3 being the referent), measures of GA, LA,
and LAxApoE interaction term. The reduced model lacked the LAxApoE interaction term.
AD � Ageþ Sexþ LAþ GAþ ApoEþ LA xApoE ð2Þ
These datasets had few ε2/� genotypes and AI/� ancestral backgrounds, so individuals with
these genotypes and ancestral backgrounds were excluded from the comparisons.
Assessment of effect sizes: Haplotype approach. A haplotype model was also tested to
assess ε4 risk in an allele-specific manner. This approach tests ε4 of a particular LA back-
ground against ε3 alleles of the same background, rather than genotypes tested in the context
of a LA “dose” across both parental haplotypes. To perform the analysis, ε3 and ε4 alleles were
grouped by their LA (AF in one and EU in the other; the sample size of AI was too small to test
adequately) and tested for association. AA and PR datasets were analyzed separately. Within
each group, the effect of the ε4 allele was assessed via logistic regression using the generalized
estimating equation (GEE), with principal components 1, 2, and 3 used as covariates and the
individual as the grouping variable. We chose the GEE to account for the individual haplotypes
correlation (since each allele is counted individually). This effectively tests the association of
AF (or EU) ε4 alleles against ε3 while controlling for the effects of global ancestry, and allows
us to estimate effect sizes of ancestry-specific haplotypes. In addition, we tested a haplotype-
based approach among the individuals with homozygote ε4 and ε3 alleles to assess the effect
size of ancestry-specific alleles on those with ε4/ε4 genotype (it was not applicable to the PR
dataset since only 12 samples had homozygote ε4 alleles.). Finally, we tested the significance of
difference between the effect sizes of ancestral backgrounds using t-test for means.
Defining potential protective variants at the LA blocks around the ApoE
To define the potential genetic factors modifying the ApoE effect size we assessed the sequence
differences between the ancestral backgrounds among the ε4 haplotypes. First, using the 1000
genomes database, we obtained genomic DNA sequence data from three populations of the
CEU, JPT, and YRI. Secondly, we extracted the ε4 haplotypes across the defined LA block of 2
mB. In addition to EU, we tested Japanese haplotypes because ε4 allele in East Asian popula-
tions has a high-risk effect as well [6,7]. Then, we performed Pearson’s chi-square test using
ApoE e4 risk in Alzheimer disease and genetic ancestry
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allele frequencies at the region of interest among the populations (CEU vs. YRI and JPT vs.
YRI) to identify the list of significantly different variants that likely contain the protective vari-
ant(s). We assessed the allele frequency difference on ε3 and ε4 haplotypes separately. To
make a list of ε4 haplotype-specific alleles with the significantly different frequencies we
removed those that showed significant difference also among the ε3 haplotypes. Finally, we
performed the Bonferroni correction [39] for the multiple comparisons.
Supporting information
S1 Table. Number of individuals and SNPs excluded after QC analysis.
(DOCX)
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